Skip to main content
Premium Trial:

Request an Annual Quote

GeneFormatics Taps IBM to Help Develop Proteomic Program (IBM s Sugar Helped)

NEW YORK, Dec. 18 — IBM will become the preferred technology partner for structural proteomics firm GeneFormatics, the companies said on Tuesday.


According to the agreement, the computer giant will provide hardware, software, and services to support GeneFormatics, and has staked a claim in the company's third round of equity financing, originally announced in October.


Financial details of the deal, including IBM's equity investment, were not disclosed.


GeneFormatics' core business is a proprietary "function first" approach to protein analysis, an effort designed to determine protein function prior to high-resolution 3-D structure analysis. GeneFormatics is betting that IBM's IT technology will help it develop this process.


The system IBM will provide will include a group of Linux-based eServer xSeries 330 systems, its Enterprise Storage Server, and a DB2 Universal database. GeneFormatics also plans to add IBM's DiscoveryLink data integration software to help organize and synthesize proteomic information.


GeneFormatics, headquartered in San Diego, Calif., had raised $22 million in its third round of financing.

The Scan

Missed Early Cases

A retrospective analysis of blood samples suggests early SARS-CoV-2 infections may have been missed in the US, the New York Times reports.

Limited Journal Editor Diversity

A survey finds low diversity among scientific and medical journal editors, according to The Scientist.

How Much of a Threat?

Science writes that need for a provision aimed at shoring up genomic data security within a new US bill is being questioned.

PNAS Papers on Historic Helicobacter Spread, Brain Development, C. difficile RNAs

In PNAS this week: Helicobacter genetic diversity gives insight into human migrations, gene expression patterns of brain development, and more.